We are live on ! Find out more
P8IP

Pier 88 Investment Partners Portfolio holdings

AUM $421M
1-Year Est. Return 14.71%
This Fund
S&P 500
This Quarter Est. Return
+6.34%
1 Year Est. Return
+14.71%
3 Year Est. Return
+36.1%
5 Year Est. Return
+43.13%
10 Year Est. Return
AUM
$471M
AUM Growth
+$138M
Cap. Flow
-$29.3M
Cap. Flow %
-6.22%
Top 10 Hldgs %
36.09%
Holding
125
New
16
Increased
39
Reduced
19
Closed
15
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SIVB
26
DELISTED
SVB Financial Group
SIVB
$2.77M 0.59%
4,080
-2,100
-34% -$1.48M
SLAB icon
27
Silicon Laboratories
SLAB
$7.2B
$2.7M 0.57%
13,068
+340
+3% +$62.6K
DXCM icon
28
DexCom
DXCM
$33.1B
$2.66M 0.57%
19,824
-2,400
-11% -$345K
KEYS icon
29
Keysight
KEYS
$57.3B
$2.65M 0.56%
12,840
+300
+2% +$56.1K
SBNY
30
DELISTED
Signature Bank
SBNY
$2.49M 0.53%
+7,700
New +$2.4M
ITT icon
31
ITT
ITT
$18.9B
$2.47M 0.53%
24,195
+2,650
+12% +$259K
SYNA icon
32
Synaptics
SYNA
$4.09B
$2.34M 0.5%
8,090
-7,400
-48% -$1.77M
ETSY icon
33
Etsy
ETSY
$7.38B
$2.16M 0.46%
9,881
-460
-4% -$111K
DDOG icon
34
Datadog
DDOG
$93.6B
$2.01M 0.43%
+11,280
New +$1.91M
ENTG icon
35
Entegris
ENTG
$22B
$2.01M 0.43%
14,500
-400
-3% -$55.9K
AQUA
36
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
$1.95M 0.41%
41,789
-45,500
-52% -$1.98M
HZNP
37
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$1.95M 0.41%
18,063
-27,385
-60% -$2.99M
PODD icon
38
Insulet
PODD
$9.91B
$1.89M 0.4%
7,107
-1,570
-18% -$455K
HELE icon
39
Helen of Troy
HELE
$680M
$1.75M 0.37%
7,150
+1,740
+32% +$413K
PRO
40
DELISTED
PROS Holdings
PRO
$1.48M 0.31%
42,840
+740
+2% +$25.4K
DNLI icon
41
Denali Therapeutics
DNLI
$4B
$1.48M 0.31%
33,080
+14,200
+75% +$673K
TSLX icon
42
Sixth Street Specialty
TSLX
$1.79B
$1.4M 0.3%
+59,703
New +$1.4M
GLD icon
43
SPDR Gold Trust
GLD
$143B
$1.37M 0.29%
8,026
RARE icon
44
Ultragenyx Pharmaceutical
RARE
$2.64B
$1.31M 0.28%
15,550
+3,460
+29% +$282K
NEE.PRQ
45
DELISTED
NextEra Energy, Inc. 6.219% Corporate Units
NEE.PRQ
$1.26M 0.27%
+21,800
New +$1.19M
LNN icon
46
Lindsay Corp
LNN
$1.17B
$1.24M 0.26%
8,135
+1,330
+20% +$203K
EVOP
47
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
$1.21M 0.26%
47,379
+23,840
+101% +$546K
PING
48
DELISTED
Ping Identity Holding Corp.
PING
$1.17M 0.25%
50,950
+10,180
+25% +$259K
FSR
49
DELISTED
Fisker Inc.
FSR
$1.15M 0.25%
+73,340
New +$1.27M
EEFT icon
50
Euronet Worldwide
EEFT
$2.65B
$1.14M 0.24%
9,551
+750
+9% +$89.1K

Similar funds

Pier 88 Investment Partners's Q4 2021 Portfolio in Review

As of Q4 2021, Pier 88 Investment Partners held 125 positions worth $471M, up 41% from $333M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Pier 88 Investment Partners withdrew a net $29.3M in Q4 2021, closing 15 positions and reducing 19 holdings. Its most notable exit was Monolithic Power Systems, an estimated $2.52M position sold in full.

By sector, the portfolio is most concentrated in Technology at 6.5% of assets, down from 11% a quarter earlier, followed by Industrials and Utilities.

Against the trend, Pier 88 Investment Partners opened a new position in Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A worth $26M.

  • Pier 88 Investment Partners's largest Q4 2021 buy was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 12,549 shares worth $26M.
  • Pier 88 Investment Partners added most to Dominion Energy, Inc. 2019 Series A Corporate Units in Q4 2021, an estimated $4.14M increase.
  • Pier 88 Investment Partners's biggest Q4 2021 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $2.99M.
  • Pier 88 Investment Partners fully exited Monolithic Power Systems in Q4 2021, selling an estimated $2.52M.
  • Pier 88 Investment Partners's ten largest holdings make up 36% of its $471M portfolio in Q4 2021.
  • Pier 88 Investment Partners opened 16 new positions and closed 15 in Q4 2021.
  • Pier 88 Investment Partners's portfolio value rose 41% quarter-over-quarter to $471M.

Based on Pier 88 Investment Partners's 13F filing for Q4 2021, filed 14 Feb 2022.